NOXXON announces launch of capital increase right issue for an amount of up to Euro 3.9 M
(WorldNews Netherlands)

NOXXON ANNOUNCES LAUNCH OF CAPITAL INCREASE RIGHT ISSUE FOR AN AMOUNT OF UP TO EUR 3.9 M Berlin, Germany, June 26, 2019, 8.00 a.m. CEST - NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX, the "Company"), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), hereby announces today the launch and terms of a share capital increase with shareholders` preferential rights for an amount of up to EUR 3.9 million (issue premium included) (the "Rights Issue"). Subscription ratio: 3 New Shares for 5 subscription rights presented Subscription price: EUR 0.65 per share (15.7% discount on the closing price on the day before the decision...